3-iodobenzylguanidine has been researched along with Amentia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MH; Yong, SW; Yoon, JH | 1 |
| Abbasi, M; Afarideh, M; Aghamollaii, V; Ahmadi, M; Farzanefar, S; Ganji, M; Ghalandari, N; Loloee, S; Naseri, M; Tafakhori, A | 1 |
| Ceriani, L; Giovanella, L; Treglia, G | 1 |
| De Deyn, PP; Engelborghs, S; Goeman, J; Hauth, L; Martin, JJ; Slaets, S; Van Acker, F; Versijpt, J | 1 |
| Matsuda, H; Mizumura, S; Waragai, M; Yamada, T | 1 |
| Kokubo, Y; Kuzuhara, S; Morimoto, S; Nomura, Y | 1 |
| Orimo, S | 1 |
| Ikeda, S; Momose, M; Nakamura, A; Oguchi, K; Ohara, S; Oide, T; Tokuda, T | 1 |
| Jindahra, P; Pulkes, T; Sirisriro, R; Sritara, C; Vejjajiva, A; Witoonpanich, R | 1 |
| Kashihara, K; Kawada, S; Ohno, M; Okumura, Y | 1 |
| Abe, K; Chikamori, T; Hanyu, H; Hida, S; Hirao, K; Iwamoto, T; Koizumi, K; Sakurai, H; Shimizu, S; Yamashina, A | 1 |
| Barker, RA | 1 |
1 review(s) available for 3-iodobenzylguanidine and Amentia
| Article | Year |
|---|---|
Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Biological Transport; Dementia; Diagnosis, Differential; Dopamine; Humans; Iodine Radioisotopes; Lewy Body Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
1 trial(s) available for 3-iodobenzylguanidine and Amentia
| Article | Year |
|---|---|
Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).
Topics: 3-Iodobenzylguanidine; Aged; Brain; Dementia; Diagnosis, Differential; Female; Heart; Humans; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
10 other study(ies) available for 3-iodobenzylguanidine and Amentia
| Article | Year |
|---|---|
Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Dementia; Dopamine Agents; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Myocardium; Parkinson Disease; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2017 |
Potential diagnostic value of
Topics: 3-Iodobenzylguanidine; Adolescent; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; ROC Curve | 2017 |
Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Dementia; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Cardiac ¹²³I-meta-iodobenzylguanidine scintigraphy in patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula, Japan.
Topics: 3-Iodobenzylguanidine; Aged; Amyotrophic Lateral Sclerosis; Dementia; Female; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Radiopharmaceuticals | 2012 |
[MIBG myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Dementia; Diagnosis, Differential; Frontotemporal Dementia; Heart; Humans; Lewy Body Disease; Radionuclide Imaging | 2011 |
Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Heart; Humans; Lewy Bodies; Male; Middle Aged; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2003 |
Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Dementia; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Memory Disorders; Myocardium; Nerve Degeneration; Neuropsychological Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2006 |
Getting to the heart of dementia.
Topics: 3-Iodobenzylguanidine; Aged; Dementia; Humans; Radiopharmaceuticals | 2001 |